ABSTRACT
Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1990; 15:691-697.
10. Gershlick AH, Spriggins D, Davies SW et al. Failure of epoprostenol (prostacyclin P012) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial. Br Heart J 1994; 71:7-15.
